PALISADE BIO Trademark

Trademark Overview


On Friday, July 31, 2020, a trademark application was filed for PALISADE BIO with the United States Patent and Trademark Office. The USPTO has given the PALISADE BIO trademark a serial number of 90086854. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, September 18, 2023. This trademark is owned by Leading BioSciences. The PALISADE BIO trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical formulations and preparations to treat acute and chronic health conditions related to gastrointestinal, inflammatory, metabolic, endocrine, immunological, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, oncological, hepatological, respiratory, neurological, psychiatric, dermatological, and viral diseases and disorders; Pharmaceutical compositions in liquid form, namely, liquid compositions containing protease inhibitors, to treat health conditions, diseases, and disorders related to the gastrointestinal tract, gastrointestinal permeability, the gastrointestinal epithelial barrier, gastrointestinal inflammation, the gastrointestinal immune system, the microbiome, and the gut-brain axis; Pharmaceutical formulations and preparations to treat or prevent surgical complications and postsurgical complications; Pharmaceutical formulations and preparations to treat or prevent shock, namely, acute shock, cardiogenic shock, septic shock, hemorrhagic shock, and shoc...
palisade bio

General Information


Serial Number90086854
Word MarkPALISADE BIO
Filing DateFriday, July 31, 2020
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, September 18, 2023
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, December 22, 2020

Trademark Statements


Goods and ServicesPharmaceutical formulations and preparations to treat acute and chronic health conditions related to gastrointestinal, inflammatory, metabolic, endocrine, immunological, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, oncological, hepatological, respiratory, neurological, psychiatric, dermatological, and viral diseases and disorders; Pharmaceutical compositions in liquid form, namely, liquid compositions containing protease inhibitors, to treat health conditions, diseases, and disorders related to the gastrointestinal tract, gastrointestinal permeability, the gastrointestinal epithelial barrier, gastrointestinal inflammation, the gastrointestinal immune system, the microbiome, and the gut-brain axis; Pharmaceutical formulations and preparations to treat or prevent surgical complications and postsurgical complications; Pharmaceutical formulations and preparations to treat or prevent shock, namely, acute shock, cardiogenic shock, septic shock, hemorrhagic shock, and shock associated with hypoperfusion; Pharmaceutical formulations and preparations to treat or prevent gastrointestinal tract injuries, ileus, and adhesions; Pharmaceutical formulations and preparations to treat or prevent multiorgan failure; Pharmaceutical formulations and preparations to treat or prevent health conditions, diseases, and disorders related to intestinal permeability, the microbiome, and the gut-brain axis
NOT AVAILABLE"BIO"

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, September 1, 2020
Primary Code005
First Use Anywhere DateThursday, January 1, 1970
First Use In Commerce DateThursday, January 1, 1970

Trademark Owner History


Party NameLeading BioSciences
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressCarlsbad, US 92008

Party NameLeading BioSciences
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressCarlsbad, US 92008

Trademark Events


Event DateEvent Description
Tuesday, August 4, 2020NEW APPLICATION ENTERED
Tuesday, September 1, 2020NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, November 19, 2020ASSIGNED TO EXAMINER
Thursday, November 19, 2020EXAMINERS AMENDMENT -WRITTEN
Thursday, November 19, 2020EXAMINERS AMENDMENT E-MAILED
Thursday, November 19, 2020NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Thursday, November 19, 2020EXAMINER'S AMENDMENT ENTERED
Thursday, November 19, 2020APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, December 2, 2020NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, December 22, 2020PUBLISHED FOR OPPOSITION
Tuesday, December 22, 2020OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, February 16, 2021NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Saturday, August 14, 2021SOU TEAS EXTENSION RECEIVED
Saturday, August 14, 2021SOU EXTENSION 1 FILED
Saturday, August 14, 2021SOU EXTENSION 1 GRANTED
Tuesday, August 17, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, February 8, 2022SOU TEAS EXTENSION RECEIVED
Tuesday, February 8, 2022SOU EXTENSION 2 FILED
Tuesday, February 8, 2022SOU EXTENSION 2 GRANTED
Thursday, February 10, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, August 15, 2022SOU TEAS EXTENSION RECEIVED
Monday, August 15, 2022SOU EXTENSION 3 FILED
Monday, August 15, 2022SOU EXTENSION 3 GRANTED
Wednesday, August 17, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, March 20, 2023ABANDONMENT - NO USE STATEMENT FILED
Monday, March 20, 2023ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Thursday, February 16, 2023SOU EXTENSION 4 FILED
Tuesday, April 4, 2023TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, April 4, 2023ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Tuesday, April 4, 2023TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Tuesday, April 4, 2023TEAS CHANGE OF CORRESPONDENCE RECEIVED
Wednesday, April 5, 2023TEAS PETITION TO REVIVE RECEIVED
Wednesday, April 5, 2023PETITION TO REVIVE-GRANTED
Wednesday, April 5, 2023SOU EXTENSION RECEIVED WITH TEAS PETITION
Thursday, April 6, 2023NOTICE OF REVIVAL - E-MAILED
Wednesday, May 24, 2023CASE ASSIGNED TO INTENT TO USE PARALEGAL
Wednesday, May 24, 2023SOU EXTENSION 4 GRANTED
Thursday, May 25, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, September 18, 2023ABANDONMENT - NO USE STATEMENT FILED
Monday, September 18, 2023ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED